Two Cases of SPEN Haploinsufficiency Presenting with Dystonia: Expanding the Genotype and Phenotype
Movement Disorders Clinical Practice, EarlyView.
Lisa Buikema +5 more
wiley +1 more source
When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions
Abstract Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood.
Ellie D. Gabriel +6 more
wiley +1 more source
Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson's disease. [PDF]
Pérez-Carasol L +8 more
europepmc +1 more source
Perspective: Depression in Persons with Parkinson's Disease
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens +1 more
wiley +1 more source
A pilot study of assessing visual hallucinations using virtual reality in lewy body disorders. [PDF]
Hirczy SS +4 more
europepmc +1 more source
Abstract Background An accurate understanding of prognosis in Parkinson's disease (PD) is important for patient information provision, personalized treatment, and clinical trial design, but most previous research has been biased towards younger, healthier patients.
Angus D. Macleod +72 more
wiley +1 more source
Resolution of Visual Hallucinations in Parkinson's Disease After Right Occipitoparietal Subcortical Hemorrhage: A Case Report. [PDF]
Nishijima H +4 more
europepmc +1 more source
Complex Visual Hallucinations in Post-stroke Epilepsy: A Case Report and Literature Review. [PDF]
Fujita S +4 more
europepmc +1 more source
Seeing Invisible Oligomers: Rethinking α‐Synuclein Pathology Through Proximity Ligation Assay
Abstract Parkinson's disease (PD) and multiple system atrophy are defined by α‐synuclein (αSYN)‐positive inclusions – Lewy bodies (LBs) and glial cytoplasmic inclusions – yet mounting evidence indicates that these inclusions represent only a fraction of disease‐relevant pathology.
Hiroaki Sekiya +3 more
wiley +1 more source

